Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29388
Title: Diabetes: a metabolic and reproductive disorder in women.
Authors: Teede H.;Thong E.P.;Codner E.;Laven J.S.E.
Monash Health Department(s): Endocrinology
Diabetes and Vascular Medicine
Institution: (Thong, Teede) Monash Centre for Health Research and Implementation, School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia (Thong, Teede) Department of Endocrinology and Diabetes, Monash Health, Clayton, VIC, Australia (Codner) Institute of Maternal and Child Research, School of Medicine, University of Chile, Santiago, Chile (Laven) Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, Netherlands
Issue Date: 25-Jan-2020
Copyright year: 2020
Publisher: Lancet Publishing Group (E-mail: cususerv@lancet.com)
Place of publication: United Kingdom
Publication information: The Lancet Diabetes and Endocrinology. 8 (2) (pp 134-149), 2020. Date of Publication: February 2020.
Journal: The Lancet Diabetes and Endocrinology
Abstract: Reproductive dysfunction is a common but little studied complication of diabetes. The spectrum of reproductive health problems in diabetes is broad, and encompasses delayed puberty and menarche, menstrual cycle abnormalities, subfertility, adverse pregnancy outcomes, and potentially early menopause. Depending on the age at diagnosis of diabetes, reproductive problems can manifest early on in puberty, emerge later when fertility is desired, or occur during the climacteric period. Historically, women with type 1 diabetes have frequently had amenorrhoea and infertility, due to central hypogonadism. With the intensification of insulin therapy and improved metabolic control, these problems have declined, but do persist. Additional reproductive implications of contemporary diabetes management are now emerging, including polycystic ovary syndrome and hyperandrogenism, which are underpinned by insulin action on the ovary. The sharp rise in type 2 diabetes incidence in youth suggests that more women of reproductive age will encounter diabetes-related reproductive problems in their lifetimes. With an ever increasing number of young women living with diabetes, clinicians need to be aware of and equipped for the challenges of navigating reproductive health concerns across the lifespan.Copyright © 2020 Elsevier Ltd
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/S2213-8587%2819%2930345-6
PubMed URL: 31635966 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31635966]
ISSN: 2213-8587
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/29388
Type: Review
Subjects: menstruation disorder
diabetes mellitus
fertility
gynecologic disease
hormonal therapy
hyperandrogenism
hypothalamus hypophysis system
insulin dependent diabetes mellitus
large for gestational age
macrosomia
menopause
metabolic disorder
non insulin dependent diabetes mellitus
ovary polycystic disease
patient care
preeclampsia
prepregnancy care
reproductive health
spontaneous abortion
stillbirth
women's health
insulin
Type of Clinical Study or Trial: Review article (e.g. literature review, narrative review)
Appears in Collections:Articles

Show full item record

Page view(s)

40
checked on Feb 5, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.